SCHEDULE: AmTrust Financial Services Reports Zero Beneficial Ownership in 180 Life Sciences Corp.

AmTrust Financial Services, Inc. and its subsidiary AmTrust International Underwriters DAC have reported zero beneficial ownership in 180 Life Sciences Corp. common stock as of July 17, 2025.

Summary

• AmTrust Financial Services, Inc. (AFSI) and AmTrust International Underwriters DAC (AIUDAC) filed an Amendment No. 1 to Schedule 13G.
• As of July 17, 2025, the Reporting Persons beneficially own 0 shares of 180 Life Sciences Corp. common stock.
• This represents 0% of the issuer's outstanding shares.
• The calculation is based on 6,039,208 shares outstanding as of June 30, 2025, as disclosed in 180 Life Sciences Corp.'s Definitive Proxy Statement filed on July 7, 2025.
• AFSI and AIUDAC each hold 0 sole voting and 0 sole dispositive power over the issuer's shares.

Sentiment

Score: 3

Explanation: The filing indicates a complete divestment of shares by a significant institutional investor, which could be perceived negatively by the market regarding the issuer's prospects or the investor's confidence in the company.

Positives

• AmTrust Financial Services, Inc. and AmTrust International Underwriters DAC have fully divested their holdings in 180 Life Sciences Corp.

Negatives

• The complete divestment of shares by a previously beneficial owner, AmTrust Financial Services, Inc. and its subsidiary, could signal a lack of confidence in 180 Life Sciences Corp.'s future prospects from a significant institutional investor.

Risks

• The divestment by a significant institutional investor may lead to negative market sentiment and potential downward pressure on 180 Life Sciences Corp.'s stock price.

Future Outlook

No forward-looking statements or guidance regarding 180 Life Sciences Corp.'s future operations or financial performance are provided by the reporting persons in this filing.

Management Comments

• The Reporting Persons certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, nor were they acquired or held in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing is a routine disclosure of a change in beneficial ownership by an institutional investor and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The divestment by a significant institutional investor may lead to negative sentiment and potential downward pressure on the stock price of 180 Life Sciences Corp.

Key Dates

Recommendation

The complete divestment of shares by AmTrust Financial Services, Inc. and its subsidiary, previously a beneficial owner, signals a lack of confidence from a sophisticated institutional investor. This action could lead to negative market sentiment and potential downward pressure on 180 Life Sciences Corp.'s stock, suggesting a 'sell' recommendation for investors currently holding the stock or considering an investment.

Keywords

180 Life Sciences Corp., AmTrust Financial Services, AmTrust International Underwriters, Schedule 13G, beneficial ownership, common stock, equity, divestment, institutional ownership